112 related articles for article (PubMed ID: 6430079)
21. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
[TBL] [Abstract][Full Text] [Related]
22. The transdermal administration of nitrates: an overview.
Demma FJ; Wilson RR
Angiology; 1983 Jan; 34(1):1-10. PubMed ID: 6401950
[TBL] [Abstract][Full Text] [Related]
23. [Discontinuous drug release as an alternative to interval therapy in the treatment of coronary heart disease with nitroglycerin patches].
Reiniger G; Rudolph W
Herz; 1987 Oct; 12(5):348-53. PubMed ID: 3119443
[TBL] [Abstract][Full Text] [Related]
24. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
[TBL] [Abstract][Full Text] [Related]
25. Acute and sustained antianginal effects of nitroglycerin patches: objective evaluation with training-effect-eliminated exercise performance index.
Dogar H; Güzelsoy D; Gültekin N; Gürses N; Demiroglu C
Am J Cardiol; 1988 Mar; 61(9):39E-43E. PubMed ID: 3126634
[TBL] [Abstract][Full Text] [Related]
26. Comparison of nitroglycerin-TTS and long-acting nitroglycerin tablets in the treatment of angina pectoris: a double-blind controlled study.
Karlson BW; Henning R
Clin Cardiol; 1987 Oct; 10(10):573-7. PubMed ID: 3117467
[TBL] [Abstract][Full Text] [Related]
27. Antianginal effects of intravenous nitroglycerin over 24 hours.
Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
[TBL] [Abstract][Full Text] [Related]
28. A randomized placebo controlled, double-blind, crossover trial of transdermal nitroglycerin in stable angina pectoris.
Rezaković DE; Pavicić L; Majacić M
Eur Heart J; 1988 Jan; 9 Suppl A():73-81. PubMed ID: 3137073
[TBL] [Abstract][Full Text] [Related]
29. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
Thadani U
Herz; 1984 Jun; 9(3):123-36. PubMed ID: 6430766
[TBL] [Abstract][Full Text] [Related]
30. Clinical experience with a transdermal nitroglycerin system.
Mahapatra RK; Mahapatra D; Yaden S
Angiology; 1987 Apr; 38(4):277-86. PubMed ID: 3107441
[TBL] [Abstract][Full Text] [Related]
31. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
Rezaković DE; Lakatos S; Stalec J; Pavicić L
Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
[TBL] [Abstract][Full Text] [Related]
32. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
Abrams J
Drugs; 1987 Sep; 34(3):391-403. PubMed ID: 3119308
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.
James MA; Walker PR; Papouchado M; Wilkinson PR
Br Heart J; 1985 Jun; 53(6):631-5. PubMed ID: 3924081
[TBL] [Abstract][Full Text] [Related]
34. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
35. [High-dose transdermal nitroglycerin therapy: loss of effect within 24 hours?].
Reiniger G; Kraus F; Dirschinger J; Blasini R; Rudolph W
Herz; 1985 Jun; 10(3):157-62. PubMed ID: 3926612
[TBL] [Abstract][Full Text] [Related]
36. A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual antianginal response after repeated administration.
Muiesan G; Agabiti-Rosei E; Muiesan L; Romanelli G; Pollavini P; Pasotti C; Fiori G; Muratori L; Zuarini AM; Pastorini C
Am Heart J; 1986 Jul; 112(1):233-8. PubMed ID: 3088963
[No Abstract] [Full Text] [Related]
37. Influence of transdermal nitrates on exercise capacity in patients with stable angina.
Thompson R
Angiology; 1986 Jun; 37(6):448-54. PubMed ID: 3089073
[TBL] [Abstract][Full Text] [Related]
38. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.
de Milliano PA; Koster RW; Bär FW; Janssen J; de Cock C; Schelling A; van de Bos A
Am J Cardiol; 1991 Oct; 68(9):857-62. PubMed ID: 1927943
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of sustained-release buccal nitroglycerin in patients with angina pectoris. New and long-acting therapy demonstrated by exercise.
Greengart A; Lichstein E; Hollander G; Bolton S; Sanders M
Chest; 1983 Mar; 83(3):473-9. PubMed ID: 6402342
[TBL] [Abstract][Full Text] [Related]
40. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]